Usema Price in India: Availability, Cost, and How to Get It

Semaglutide in India: A Guide to Availability, Cost, and Access

Semaglutide is a medication that has gathered significant attention globally for its role in managing type 2 diabetes and, in certain formulations, chronic weight management. As awareness grows in India, many people have practical questions: Is it available here? What does it cost? And how can one access it safely and legally?

This article serves as a clear and straightforward guide to understanding the landscape of semaglutide in India, including the Usema brand. We will walk through its availability, the factors that influence its price, and the proper steps to obtain it. Consult your healthcare provider before starting any medication.

What is Usema?

Usema is a brand of semaglutide injection launched in India on 21 March 2026 by USV Private Limited, which co-markets Dr. Reddy's Laboratories' semaglutide. It was launched for type 2 diabetes in 2mg and 4mg pre-filled pens, with an 8mg pen said to be coming later. At launch, ET Pharma reported a starting price of Rs 4,300. This is a dated launch figure; check the current MRP for your prescribed pen.

Availability note (October 2026): Usema is Dr. Reddy's semaglutide, co-marketed by USV. In July 2026 Dr. Reddy's paused commercial supplies of its semaglutide injection after some batches were found out of specification because of an active-ingredient issue, and said there was no impact on patient safety. We could not confirm how this affected Usema stock, so check current availability with your pharmacist and do not change brand or dose without your prescriber.

What is Semaglutide?

Semaglutide belongs to a class of medications known as GLP-1 (glucagon-like peptide-1) receptor agonists. In simple terms, it works by mimicking a hormone in your body that helps regulate blood sugar and appetite. This dual action is why it's used for two distinct, though often related, health goals:

• Glycemic Control: For adults with type 2 diabetes, it helps the body release more insulin when blood sugar is high, which aids in managing glucose levels.
• Chronic Weight Management: By acting on brain centers that control appetite, it can help reduce hunger and calorie intake, supporting weight loss efforts in eligible individuals.

In India, as in other countries, semaglutide is available in different forms, such as a once-daily oral tablet or a once-weekly injection. Approved uses differ by brand: Usema, for example, was launched for type 2 diabetes. It is strictly a prescription medication, meaning you cannot and should not purchase it over the counter.

Availability of Semaglutide in India

The straightforward answer is yes, semaglutide is legally available in India. Products are approved by the Drugs Controller General of India (DCGI) at the Central Drugs Standard Control Organisation (CDSCO) for specific medical uses, and many generic brands launched after the patent expired in March 2026.

Where to Find It

You can obtain semaglutide with a valid prescription from:

• Licensed Pharmacies: Pharmacy chains and local chemists may stock it; stock of a specific brand and strength varies.
• Hospital Pharmacies: Some hospitals and specialty clinics may have it available for their patients.

Because it is a prescription-only medicine, a pharmacist should see a prescription from a registered medical practitioner before dispensing it.

Understanding Stock and Supply

Availability of a specific brand can fluctuate from one pharmacy to another and from one month to the next. For example, Dr. Reddy's paused supplies of its semaglutide injection from July 2026, which may affect brands made from its product.

If you are prescribed this medication, it is a good idea to call your pharmacy in advance to confirm they have it in stock. Building a good relationship with your local pharmacist can also be helpful, as they may be able to inform you about expected availability or place an order for you.

The Cost of Semaglutide in India

The price of semaglutide is a significant consideration for many individuals. There is no single fixed price, as the final cost you pay can be influenced by several key factors.

Factors That Influence the Price

• Formulation: The cost differs between the oral tablets and the injectable pens. Each format has its own pricing structure.
• Dosage and Strength: Semaglutide comes in various strengths. A higher dose or a pen containing more medication will naturally cost more than a starter dose.
• Brand and Manufacturer: Different pharmaceutical companies market semaglutide under different brand names, which may come with slight price variations.
• Pharmacy and Location: The final retail price can vary slightly depending on the pharmacy's markup and your geographical location within India.

General Price Expectations

Prices fell after generic semaglutide brands launched in March 2026. As dated examples: USV's Usema launched at a starting price of Rs 4,300 (March 2026), Dr. Reddy's own Obeda pens at Rs 4,200 per month, and Novo Nordisk cut Ozempic prices from 1 April 2026 to about Rs 5,660-9,100 depending on strength.

These figures are dated launch and media prices, not current offers, and can change. The best way to know the exact cost is to take your prescription to a few different pharmacies and ask for the current price.

Does Insurance Cover Semaglutide?

Insurance coverage for semaglutide in India is not yet widespread and depends heavily on your individual policy. Coverage is more likely if the medication is prescribed for its approved indication of managing type 2 diabetes. Coverage for weight management may be less common. It is essential to contact your insurance provider directly to understand the specifics of your plan, including any documentation or pre-authorizations they may require.

How to Get a Prescription for Semaglutide

Accessing semaglutide starts with a conversation with a qualified doctor. This is the most crucial step for ensuring your safety and the medication's effectiveness.

The Right Way to Access Treatment

1. Schedule a Doctor's Appointment: The first step is to consult a healthcare professional. An endocrinologist or a diabetologist is often the most appropriate specialist, but a knowledgeable general physician can also guide you.
2. Undergo a Medical Evaluation: Your doctor will conduct a thorough evaluation of your health. This includes reviewing your medical history, discussing your health goals, checking your weight and BMI, and likely ordering blood tests (such as HbA1c for diabetes) to get a complete picture.
3. Determine if It's Right for You: Based on this evaluation, your doctor will determine if semaglutide is a safe and appropriate treatment for your specific condition, according to established medical guidelines. They will discuss the potential benefits and side effects with you.
4. Receive Your Prescription: If you and your doctor agree that this is the right path, they will provide a valid prescription. This will specify the brand, the correct starting dose, and instructions on how to take it.

The Importance of a Prescription

Obtaining this medication without a doctor's guidance is risky and illegal. A prescription ensures that your health is being professionally monitored, that the dosage is appropriate for you, and that you are using an authentic product from a legitimate source.

Your Health Journey

Starting any new medication is a significant decision. Semaglutide is intended to be used as part of a comprehensive health plan that includes a balanced diet and regular physical activity. Your doctor will work with you to create this holistic plan and schedule follow-up appointments to monitor your progress and manage any side effects.

Remember that navigating your health is a partnership between you and your healthcare team. Open communication, realistic expectations, and consistent follow-through are key to achieving your wellness goals. Consult your healthcare provider before starting any medication.

Sources

• ET Pharma: USV and Dr Reddy's launch Usema at a starting price of Rs 4,300 (22 March 2026): https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/usv-dr-reddys-semaglutide-generic-hits-market-at-4300/129721908
• BioSpectrum India: USV launches Usema with Dr. Reddy's (21 March 2026): https://biospectrumindia.com/news/16/27530/usv-launches-usema-to-address-indias-metabolic-health-burden.html
• Dr. Reddy's Obeda injection launch release (21 March 2026): https://www.drreddys.com/cms/sites/default/files/2026-03/finalpressrelease-Dr.Reddy%27sSemalaunch-21stMarch2026.pdf
• Dr. Reddy's delays commercial semaglutide supplies after an ingredient issue (Daily Excelsior/PTI, 9 July 2026): https://www.dailyexcelsior.com/dr-reddys-delays-anti-diabetic-semaglutide-commercial-supplies-after-issues-with-ingredient/
• Ozempic and Wegovy India price ranges after the April 2026 cut (Outlook Business, 31 March 2026): https://www.outlookbusiness.com/corporate/novo-nordisk-cuts-ozempic-wegovy-prices-by-up-to-48-amid-generic-pressure
• Central Drugs Standard Control Organisation (CDSCO): https://cdsco.gov.in
• Ministry of Health and Family Welfare, Government of India: https://www.mohfw.gov.in
• World Health Organization (WHO) India: https://www.who.int/india
• Drugs and Cosmetics Act and Rules (CDSCO PDF): https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf